secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-06-03T21:00:52+00:00
Accession:  0001213900-26-064804
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026
-------------------------------------------------------------------------

- Every 15 shares of common stock combined into 1 share; par value unchanged at $0.0001.
- Authorized shares reduced proportionately from 100M to approximately 6.67M.
- Fractional shares rounded up to the next whole share; no fractional shares issued.
- Common stock trades under same symbol SILO but with new CUSIP 82711P 300.
- Split-adjusted trading began on The Nasdaq Capital Market on June 3, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/0001213900-26-064804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026064804/ea0293111-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-064804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer